MTL-CEBPA
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MTL-CEBPA, covering 2025-03-06 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma. [Phase 1]